Loading company…
SurModics develops surface modification technologies and chemical components for medical devices and diagnostics.
SurModics develops coatings for intravascular medical devices and chemical components used in in vitro diagnostics. Its products include hydrophilic, hemocompatible, and drug-delivery coatings, as well as balloon catheter designs and assay components. Founded in 1979, the company was based in Minnesota, US. GTCR acquired it in May 2024 for approximately USD 627 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in